| Page 1215 | Kisaco Research
 

Missy Lavendar

CEO & Founder
Renalis Health

Missy Lavendar

CEO & Founder
Renalis Health

Missy Lavendar

CEO & Founder
Renalis Health
 

Michelle Mielke

Professor of Epidemiology; Professor of Gerontology & Geriatric Medicine
Wake Forest School of Medicine

Michelle M. Mielke, Ph.D. is Chair of the Department of Epidemiology and Prevention and Professor of Epidemiology and of Gerontology and Geriatric Medicine at Wake Forest University School of Medicine. Dr. Mielke works as a translational epidemiologist to further understanding of the etiology and epidemiology of neurodegenerative and other aging-related diseases.  One focus of her research is understanding the utility of blood-based biomarkers at the population for screening and diagnosing Alzheimer’s disease and related dementias. Another focus of Dr.

Michelle Mielke

Professor of Epidemiology; Professor of Gerontology & Geriatric Medicine
Wake Forest School of Medicine

Michelle Mielke

Professor of Epidemiology; Professor of Gerontology & Geriatric Medicine
Wake Forest School of Medicine

Michelle M. Mielke, Ph.D. is Chair of the Department of Epidemiology and Prevention and Professor of Epidemiology and of Gerontology and Geriatric Medicine at Wake Forest University School of Medicine. Dr. Mielke works as a translational epidemiologist to further understanding of the etiology and epidemiology of neurodegenerative and other aging-related diseases.  One focus of her research is understanding the utility of blood-based biomarkers at the population for screening and diagnosing Alzheimer’s disease and related dementias. Another focus of Dr. Mielke’s research is on understanding sex and gender differences in the development and progression of Alzheimer’s disease and of other aging-related conditions. She directs the Mayo Clinic Specialized Center of Research Excellence (SCORE) on Sex Differences. Dr. Mielke is co-Chair of the Sex and Gender Diversity Group for the Alzheimer’s Association Professional Interest Area. She received the John R. Raymond Mentor Award from the Women Scholars Initiative. She is the PI of several NIH-funded clinical- and epidemiological-based grants and has published over 360 manuscripts.

 

Lucy Perez

PhD, Senior Principal
McKinsey & Company

Lucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.

Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America.  She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.

Lucy Perez

PhD, Senior Principal
McKinsey & Company

Lucy Perez

PhD, Senior Principal
McKinsey & Company

Lucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.

Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America.  She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.

 

Lina Borgo

CO- Founder
Mina Health

Lina Borgo

CO- Founder
Mina Health

Lina Borgo

CO- Founder
Mina Health
 

Kelle Moley

Global VP of Clinical and Translational R&D, Reproductive Medicine & Maternal Health
Ferring Pharmaceuticals

Kelle Moley

Global VP of Clinical and Translational R&D, Reproductive Medicine & Maternal Health
Ferring Pharmaceuticals

Kelle Moley

Global VP of Clinical and Translational R&D, Reproductive Medicine & Maternal Health
Ferring Pharmaceuticals
 

Kalahn Taylor-Clark

Faculty in Executive Education
The Johns Hopkins University

Kalahn Taylor-Clark

Faculty in Executive Education
The Johns Hopkins University

Kalahn Taylor-Clark

Faculty in Executive Education
The Johns Hopkins University
 

Jessica Karr

Founding General Partner
Coyote Ventures

Jessica Karr is a Founding General Partner of Coyote Ventures, an early stage venture capital fund investing in women’s health and wellness. Jessica worked for 6+ years designing and launching the Impossible burger as the 12th employee, has worked with international startups on product strategy and helped launched impact-focused funds. 

Jessica Karr

Founding General Partner
Coyote Ventures

Jessica Karr

Founding General Partner
Coyote Ventures

Jessica Karr is a Founding General Partner of Coyote Ventures, an early stage venture capital fund investing in women’s health and wellness. Jessica worked for 6+ years designing and launching the Impossible burger as the 12th employee, has worked with international startups on product strategy and helped launched impact-focused funds. 

Jessica Karr is a Founding General Partner of Coyote Ventures, an early stage venture capital fund investing in women’s health and wellness. Jessica worked for 6+ years designing and launching the Impossible burger as the 12th employee, has worked with international startups on product strategy and helped launched impact-focused funds. 

 

Jamie White

Health Science Strategist

Jamie White

Health Science Strategist

Jamie White

Health Science Strategist
 

Hasti Nazem

Head of Product & Education
Kindra

Hasti is part of the founding team of Kindra, leading product development and education. Kindra is developing innovative estrogen-free solutions targeting the top pain points of the 34+ symptoms of menopause. With nearly 10 years of experience at the intersection of life sciences, health and wellness, and consumer brand building, Hasti integrates targeted product formulation development with cutting edge technical advancements. Her deep scientific communications experience helps to empower consumers to better understand their health, and bridge gaps often overlooked in women's health.

Hasti Nazem

Head of Product & Education
Kindra

Hasti Nazem

Head of Product & Education
Kindra

Hasti is part of the founding team of Kindra, leading product development and education. Kindra is developing innovative estrogen-free solutions targeting the top pain points of the 34+ symptoms of menopause. With nearly 10 years of experience at the intersection of life sciences, health and wellness, and consumer brand building, Hasti integrates targeted product formulation development with cutting edge technical advancements. Her deep scientific communications experience helps to empower consumers to better understand their health, and bridge gaps often overlooked in women's health. Hasti's work has been featured in has been featured in The New York Times, Forbes.com, (O) Oprah Magazine, Harper's Bazaar, Women's Health Magazine, and in healthcare public affairs and pharmaceutical trade association publications.

 

Elizabeth Garner

MD, MPH, Chief Scientific Officer, US
Ferring Pharmaceuticals

Elizabeth Garner

MD, MPH, Chief Scientific Officer, US
Ferring Pharmaceuticals

Elizabeth Garner

MD, MPH, Chief Scientific Officer, US
Ferring Pharmaceuticals